Resources Top 5: McLaren’s monster mineral sands upgrade tips the global titanium scale
Health Check: ALS waves off a Mexican drug testing downturn to post a 12pc profit rise
Why married couples are signing ‘mid-nups’ to protect their wealth
Lunch Wrap: ASX hammered to four-month low as TechnologyOne leads tech carnage
Chinese hackers ‘tricked’ Anthropic AI into launching cyber attacks
Biocurious: Inhalerx hones in on pot for pain and panic in its quest for historic drug approval
Top 10 at 11: ASX slips below 200-day average as markets puke tech stocks
Bacterial or viral? Lumos moves to close a widening diagnostic gap as respiratory cases rise
Long Shortz with Buxton Resources: High-impact targets shape BUX’s next exploration push
Rise and Shine: Everything you need to know before the ASX opens
Contributors
Our Resident Experts
Mining
Resources Top 5: Five-year Plutonic stoush ends with $48m win for Zuleika Gold
Kristie Batten: Ark sets sights on becoming Queensland’s first rare earths producer
Barry FitzGerald: As tailwinds blow, Caravel’s giant WA copper deposit has massive upside
True Width: Lincoln Liu on rebuilding US antimony play Red Mountain Mining from the ground up
Gold Digger: Gold’s surge may have halted for now, but expect miners to keep building cash
Featured in Mining
Tech
Why AI’s big short is not done yet
Defence dollars are surging, and ASX companies like Harvest Tech are plugged in
Rokt clinches US$7.9bn valuation in pre-IPO positioning frenzy
Younger Aussies beat power bills with payment hacks
Quantum shockwave hits finance as Aussie companies join the race
Featured in Tech
Health & Biotech
Biocurious: Inhalerx hones in on pot for pain and panic in its quest for historic drug approval
Bacterial or viral? Lumos moves to close a widening diagnostic gap as respiratory cases rise
Health Check: Genetic Signatures holds course as Island climbs on FDA breakthrough
Dr Boreham’s Crucible: Paradigm takes its biggest step yet in the long walk to knee OA relief
Micro-X powers ahead with partnerships to advance next-gen X-ray tech
Featured in Health & Biotech
Experts
Salary sacrifice falls out of favour as a super strategy
Criterion: The RBA might not lower rates again – but does it matter for shares?
Why a rental shortage is stopping sellers and fuelling home prices
Shutdown ends as markets brace for torrent of delayed US data
The next potential wealth tax coming for investors
Bonds well positioned to play a stronger role in investor portfolios
Term deposit interest rates have a bright future for savers and seniors
